Interleukin 33 (IL33) Antibody (FITC)

Este producto es parte de IL33 - Interleukin 33
Product Graph
169€ (20 µg)

Por favor contáctenos para obtener información detallada sobre el precio y disponibilidad.

935106861
info@markelab.com
name
Interleukin 33 (IL33) Antibody (FITC)
category
Primary Antibodies
provider
Abbexa
reference
abx314189

Description

IL33 Antibody (FITC) is a Rabbit Polyclonal against IL33 conjugated to FITC.

Documents del producto

Instrucciones
Data sheet
Descargar

Product specifications

Category
Primary Antibodies
Immunogen Target
Interleukin 33 (IL33)
Host
Rabbit
Reactivity
Human
Recommended Dilution
Optimal dilutions/concentrations should be determined by the end user.
Clonality
Polyclonal
Conjugation
FITC
Isotype
IgG
Purity
> 95%
Purification
Purified by Protein G.
Size 1
20 µg
Size 2
50 µg
Size 3
100 µg
Size 4
200 µg
Size 5
1 mg
Form
Liquid
Buffer
0.01 M PBS, pH 7.4, 0.03% Proclin-300 and 50% Glycerol.
Availability
Shipped within 5-10 working days.
Storage
Aliquot and store at -20°C. Avoid exposure to light. Avoid repeated freeze/thaw cycles.
Dry Ice
No
UniProt ID
O95760
Gene ID
90865
NCBI Accession
NP_001186569.1, NM_001199640.1, NP_001186570.1, NM_001199641.1, NP_001300973.1, NM_001314044.1
OMIM
608678
Alias
IL33,IL-33,C9orf26,IL1F11,IL-1F11
Background
Antibody anti-IL33
Status
RUO

Descripción

IL33 is a nuclear alarmin cytokine belonging to the IL-1 family, released during cellular stress, injury, or necrosis to alert the immune system and promote inflammation. IL33 binds to its receptor IL1RL1 (ST2) and forms a signaling complex with IL1RAP, leading to activation of NF-κB and MAPK pathways, which drive cytokine production, immune cell activation, and tissue repair. IL33 primarily targets type 2 immune cells, including Th2 cells, innate lymphoid cells (ILC2s), mast cells, and eosinophils, to regulate allergic inflammation, tissue homeostasis, and anti-helminth immunity. It is abundantly expressed in epithelial cells, endothelial cells, and fibroblasts, where it functions as both a cytokine and a transcriptional regulator. Dysregulated IL33 signaling contributes to allergic diseases, such as asthma, atopic dermatitis, and rhinitis, as well as inflammatory and fibrotic disorders. In tumors, IL33 can promote both pro- and anti-tumor immune responses depending on the context. Knockout studies reveal reduced type 2 cytokine production, impaired tissue repair, and weakened immune responses, highlighting IL33’s role in inflammation, tissue homeostasis, and immunity.

Related Products

EH0198

Human IL-33(Interleukin-33) ELISA Kit

Ver Producto
EM0118

Mouse IL-33(Interleukin 33) ELISA Kit

Ver Producto
ER1903

Rat IL-33(Interleukin-33) ELISA Kit

Ver Producto